Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using...

download Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire

of 8

Transcript of Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using...

  • 7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire

    1/8

    http://jcn.sagepub.com/Journal of Child Neurology

    http://jcn.sagepub.com/content/early/2012/10/18/0883073812461564The online version of this article can be found at:

    DOI: 10.1177/0883073812461564

    published online 30 October 2012J Child NeurolZarrin Keihani-Doust, Maryam Saeedi, Tahere Esmaeilni, Massoud Habibi and Seyed Saeed Hashemi NazariAge and Stages Questionnaire

    o-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Us

    Published by:

    http://www.sagepublications.com

    can be found at:Journal of Child NeurologyAdditional services and information for

    http://jcn.sagepub.com/cgi/alertsEmail Alerts:

    http://jcn.sagepub.com/subscriptionsSubscriptions:

    http://www.sagepub.com/journalsReprints.navReprints:

    http://www.sagepub.com/journalsPermissions.navPermissions:

    What is This?

    - Oct 30, 2012OnlineFirst Version of Record>>

    at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from at UNIVERSITAS GADJAH MADA on September 21, 2013jcn.sagepub.comDownloaded from

    http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/content/early/2012/10/18/0883073812461564http://jcn.sagepub.com/content/early/2012/10/18/0883073812461564http://www.sagepublications.com/http://jcn.sagepub.com/cgi/alertshttp://jcn.sagepub.com/cgi/alertshttp://jcn.sagepub.com/subscriptionshttp://jcn.sagepub.com/subscriptionshttp://jcn.sagepub.com/subscriptionshttp://www.sagepub.com/journalsReprints.navhttp://www.sagepub.com/journalsReprints.navhttp://www.sagepub.com/journalsPermissions.navhttp://online.sagepub.com/site/sphelp/vorhelp.xhtmlhttp://online.sagepub.com/site/sphelp/vorhelp.xhtmlhttp://online.sagepub.com/site/sphelp/vorhelp.xhtmlhttp://jcn.sagepub.com/content/early/2012/10/18/0883073812461564.full.pdfhttp://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://jcn.sagepub.com/http://online.sagepub.com/site/sphelp/vorhelp.xhtmlhttp://jcn.sagepub.com/content/early/2012/10/18/0883073812461564.full.pdfhttp://www.sagepub.com/journalsPermissions.navhttp://www.sagepub.com/journalsReprints.navhttp://jcn.sagepub.com/subscriptionshttp://jcn.sagepub.com/cgi/alertshttp://www.sagepublications.com/http://jcn.sagepub.com/content/early/2012/10/18/0883073812461564http://jcn.sagepub.com/
  • 7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire

    2/8

    Original Article

    Two-Year Follow-Up Study onNeurodevelopmental Outcomes AfterTerm Intrapartum Asphyxia Using Age

    and Stages Questionnaire

    Zarrin Keihani-Doust, MD1

    , Maryam Saeedi, MD, MPH1

    ,Tahere Esmaeilni, MD1, Massoud Habibi, MD2, and

    Seyed Saeed Hashemi Nazari, MD, MPH, PhD3

    Abstract

    Birth asphyxia is one of the multiple causes of neonatal encephalopathy. The objective of this study was to evaluate neurode-

    velopmental outcomes of newborn term infants with definitive asphyxia. Thirty infants met study criteria for asphyxia. The 5-yearincidence of asphyxia was estimated to be 5.5 in 1000. According to the Age and Stage Questionnaire, 10.5% of 6-month-oldinfants, 14.3% of 12- and 18-month-old infants, and 5.3% of 24-month-old infants had neurodevelopmental delay in gross motorfunction in the absence of cerebral palsy. In 7.3% of 18-month-old infants, neurodevelopmental delay in problem-solving abilitywas observed. Higher values of Apgar score and bicarbonate levels were associated with higher Age and Stage Questionnaire

    total score. Delivery type, maternal age, gravidity of mother, and existence of mother disease during pregnancy were alsoassociated with lower Age and Stage Questionnaire total score in different stages of life.

    Keywords

    neurodevelopmental delay, Age and Stage Questionnaire, Apgar, asphyxia, term infant, encephalopathy

    Received June 18, 2012. Accepted for publication August 27, 2012.

    Encephalopathy is the result of brainmalfunction that can be clas-

    sified as acute versus chronic or stable versus progressive. About

    80% of full-term infants with encephalopathy have acute injuries,

    3% have nonhypoxic ischemia and less than 1% have prenatal

    injuries. Different disorders in mother can cause fetal hypoxia,

    including low maternal blood pressure, inadequate oxygenation

    of maternal blood, inadequate relaxation of uterus caused by

    excessive administration of oxytocin, premature separation of

    placenta, placental insufficiency, and compression of cord.1

    Birth asphyxia is one of the multiple causes of neonatal ence-

    phalopathy.2 Although in some studies these 2 terms are consid-

    ered the same, in the literature on neonatal encephalopathy, once

    infants with major malformations, drugs, metabolic causes, and

    infections are excluded, the remaining cases are assumed to be

    asphyxia related.3 Hypoxic-ischemic encephalopathy is

    classified according to assessment of feeding, alertness, tone,

    body posture, tendon reflexes, myoclonus, Moro reflex, cornea

    situation, duration of signs, and electroencephalogram (EEG)

    abnormalities into 3 stages. The prognosis of stage 1 is good.

    Stage 2 has varied prognosis and stage 3 or persistence of stage

    2 for more than 7 days or failure of EEG to revert to normal is

    associated with neurodevelopmental impairment or death.

    Expected outcomes for a term newborn with intrapartum

    asphyxia are normality, death, or a neurodevelopmental

    disability.4

    Hypoxic-ischemic encephalopathy usually occurs in 1 to 2

    per 1000 newborn infants.5 Almost, 20% of infants with

    hypoxic-ischemic encephalopathy die during infancy and

    25% suffer from permanent neurodevelopmental impairment.

    To our knowledge, few studies have been done on the neu-

    rodevelopmental function of term infant with asphyxia in

    developing countries and in our country this study is the first

    1 Department of Pediatrics, Imam Hospital, Tehran University of Medical

    Sciences, Tehran, Iran2 Iranian center for Breast Cancer, Academic Center for Education, Culture

    and Research, Tehran, Iran3 Department of Epidemiology and Biostatistics, Tehran University of Medical

    Sciences, School of public Health, Tehran, Iran

    Corresponding Author:

    Maryam Saeedi, MD, MPH, Department of Pediatrics, Imam Hospital, Tehran

    University of Medical Sciences, Gharib Street, Keshavarz Boulevard, Tehran,

    Iran

    Email: [email protected]

    Journal of Child Neurology

    00(0) 1-7

    The Author(s) 2012

    Reprints and permission:

    sagepub.com/journalsPermissions.nav

    DOI: 10.1177/0883073812461564

    http://jcn.sagepub.com

  • 7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire

    3/8

    in this field. The objective of our study was to evaluate neuro-

    developmental outcomes of a cohort of newborn term infants

    with defined asphyxia. These outcomes were measured by Age

    and Stages Questionnaire.

    MethodsStudy Population

    All deliveries were scanned in a university-based pediatric hospital

    between 2007 and 2011 in the capital city of Iran, Tehran. Infants who

    met our criteria for definition of intrapartum hypoxia and were born at

    term (ie, greater than 36 weeks gestation) were enrolled in a prospec-

    tive cohort study with a 24-month follow-up. Infants who suffered

    from metabolic diseases or congenital abnormalities were excluded

    from this study.

    Asphyxia Definition

    There is not any global agreement on definition of asphyxia. Our

    review literature showed that 3 sets of criteria are used mostly fordiagnosis of asphyxia. According to the American Academy of

    Pediatrics and the American College of Obstetrics and Gynecology

    in 1996,6

    intrapartum hypoxia was defined by profound acidosis (cord

    pH

  • 7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire

    4/8

    38.7 weeks; 26.7% had 37 weeks, 23.3% had 38 weeks, 16.7%

    had 39 weeks, 20% had 40 weeks, and 13.3% had more than 40

    weeks. Twenty-five infants (83.3%) received positive-pressure

    ventilation at the time of delivery, 20% received cardiac resusci-

    tation, and for 20% intratracheal intubation was performed. From

    these infants, 23.3% had seizures within 3 days following the

    delivery. Imaging studies wereperformed on the neonate who had

    clinical signs of hypoxia. Brain ultrasonography was performed

    on 24 infants and brain computed tomography was performed

    on 7 infants. Acute asphyxia changes including intraventricular

    hemorrhage, periventricular leukomalacia, choroid plexus cyst

    and ventriculomegaly were observed in 5 ultrasonographic and

    3 computed tomographic scans.

    Of 30 infants with asphyxia, 3 (10%) died (2 on the first day

    and 1 on the 19th day of life). There was a statistically

    significant association between seizure (P .009), intubation

    (P .005), and abnormal finding in brain ultrasonography

    (P .022) and death outcome. We could not find any signifi-

    cant differences in the pH level, base deficit, and the Apgar

    score of infants who died in comparison to other infants.

    Age and Stage Questionnaire Scores in 6-Month-OldInfants

    All the infants received higher than the cut-off score in commu-

    nication, fine motor function, problem-solving ability, and

    personal-social area. In 10.5% of infants, gross motor function

    was lower than the cut-off score. To define the predictors of

    neurodevelopmental outcomes, the association of the total

    score of the Age and Stage Questionnaire and the score in each

    of the 5 neurodevelopmental areas and maternal and neonatal

    variables were evaluated in separate univariate regression

    models. From maternal and neonatal variables, Apgar score and

    bicarbonate levels in blood were associated positively with the

    total Age and Stage Questionnaire Score and the base deficit was

    associated negatively with the total Age and Stage Questionnaire

    score. The results of fitted models are presented in Table 2. Age

    and Stage Questionnaire scores of each of the 5 neurodevelop-

    ment areas were also regressed on maternal and neonatal

    variables.

    The communication score was not associated with any of the

    defined maternal and neonatal variables. The gross motor score

    was associated positively with the Apgar score. The fine motor

    score was associated negatively with delivery type (cesarean

    section vs normal vaginal delivery), gravidity of mother, and

    mother disease during pregnancy. The problem-solving ability

    score was associated negatively with the base deficit and

    positively with the bicarbonate level. The personal-social score

    was associated positively with the Apgar score and the bicarbo-nate level and negatively with the base deficit. The results of

    fitted models are presented in Table 3.

    Age and Stage Questionnaire Scores in 12-Month-Old

    Infants

    All the infants received higher than the cut-off score in commu-

    nication, fine motor function, problem-solving ability, and

    personal-social area. In 14.3% of infants, gross motor function

    was lower than the cut-off score. Again, separate univariate

    models were fitted to define the maternal and neonatal vari-ables that affect the Age and Stage Questionnaire score. From

    the maternal and neonatal variables, the mean bicarbonate level

    of the blood samples was associated positively with the total

    Age and Stage Questionnaire score and the base deficit was

    negatively associated. The results of fitted models are

    presented in Table 2.

    The communication score was associated positively with

    positive-pressure ventilation. The gross and fine motor scores

    were associated negatively with base deficit and positively with

    the bicarbonate level. The problem-solving ability score and

    the personal-social score were associated negatively with birth

    weight. The results of fitted models are presented in Table 3.

    Age and Stage Questionnaire Scores in 18-Month-Old

    Infants

    In this age, only the gross motor function and problem-solving

    abilities were abnormal in 14.3% and 7.1% of infants respec-

    tively. Univariate analysis of the neonatal and maternal factors

    showed a positive effect for Apgar score on the Age and Stage

    Questionnaire score. The maternal age and the mothers disease

    during pregnancy demonstrated a negative effect. For a 5-year

    increment in mothers age, the Age and Stage Questionnaire

    score decreased by 4.25 points. The infants of mothers who had

    a disease during pregnancy, had, on average, an Age and Stage

    Questionnaire Score that was 14 points less than other infants.

    The results of fitted models are presented in Table 2.

    The communication score was associated negatively with the

    existence of a disease inside the mother during pregnancy. The

    gross motor score was associated positively with bicarbonate

    levels. The fine motor score was not associated with any of the

    defined maternal and neonatal variables. The problem-solving

    ability score was associated negatively with base deficit and posi-

    tively with bicarbonate levels. The personal-social score was not

    associated with any of the defined maternal and neonatal

    variables. The results of fitted models are presented in Table 3.

    Table 1. Numbers of Infants With Each of the Inclusion Criteria

    Inclusion criteria n (%)

    Range

    AverageMin Max

    Cord blood pH 12 13 (43.3) 21 4.7 12.25-minute Apgar scores

  • 7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire

    5/8

    Age and Stage Questionnaire Scores in 24-Month-Old

    Infants

    At this stage, just the gross motor function was under the

    cut-off limit in 5.3% of infants and all other neurodevelopmen-

    tal areas were normal. Univariate analysis showed a positive

    association between Age and Stage Questionnaire Score and

    bicarbonate levels and a negative weak association between

    base deficit and the Age and Stage Questionnaire Score. The

    results of fitted models are presented in Table 2. The commu-

    nication score was associated negatively with the mother

    disease during pregnancy and positively with positive pressure

    ventilation. The gross motor score was associated positively

    with the Apgar score and negatively with maternal age and

    maternal disease. The fine motor score was not associated with

    any of the defined maternal and neonatal variables. The

    problem-solving ability score was associated negatively with

    the base deficit and the mothers disease and positively with the

    Apgar score and seizure occurrence in infants. The personal-

    social score was associated negatively with the childs birth

    weight. The results of fitted models are presented in Table 3.

    Discussion

    Intrapartum asphyxia is only one of the many possible causes

    of neonatal encephalopathy.12 Approximately 15% to 20% of

    infants with neonatal encephalopathy will die during the new-

    born period, and 25% of the survivors will sustain permanent

    clinical deficits.5 Only 10% of infants with evidence of hypoxic

    ischemic encephalopathy develop cerebral palsy.13 In our

    study, 3 of 30 infants with asphyxia (10%) died. The lack of

    an objective marker of term intrapartum asphyxia has clouded

    efforts to clinically diagnose intrapartum asphyxia and to

    understand its potential range of adverse outcomes.

    Some studies have shown that in the absence of cerebral

    palsy, a neurodevelopmental disability is a relatively common

    consequence of term intrapartum asphyxia, which occurs in

    approximately 41.5% of patients.12

    Some other studies have documented much lower

    prevalence for a variety of adverse neurologic outcomes,

    including motor, cognitive, memory, language, learning, and

    behavioral deficits and limitations that may reach the threshold

    for the diagnosis of a specific neurodevelopmental disability(including global developmental delay, mental retardation or

    intellectual disability, attention deficit hyperactivity disorder,

    learning disabilities, developmental language impairment,

    autistic spectrum disorders, epilepsy, and secondary microce-

    phaly) in absence of cerebral palsy in term intrapartum

    asphyxia.4,5

    In the current study, 10.5% of 6-month-old infants, 14.3% of

    12- and 18-month-old infants and 5.3% of 24-month-old

    infants had neurodevelopmental delay in gross motor function

    in the absence of cerebral palsy. In 7.3% of 18-month-old

    infants, neurodevelopmental delay in problem solving ability

    was observed. These findings are in accordance with other

    studies in this field.5,12

    Prior studies have shown that clinical and biochemical

    variables, such as umbilical artery blood gases or Apgar scores,

    are of limitedvalue in predicting neurodevelopmental outcomes.5

    In our study, a higher value of Apgar score was a predictor of

    higher Age and Stage Questionnaire total score and also better

    gross motor and personal-social function and problem-solving

    ability. Higher level of bicarbonate was also a predictor of higher

    total Age and Stage Questionnaire score and better gross and fine

    motor function, problem-solving ability, and personal-social

    function. Base deficit was associated negatively with Age and

    Stage Questionnaire total score and also gross motor, personal-

    social function and problem solving ability.

    Table 2. Regression of Age and Stage Questionnaire Total Scores on Maternal and Neonatal Factors in 6-, 12-, 18-, and 24-Month-Old Infants

    6th month 12th month 18th month 24th monthCoeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI) Coeff. (95% CI)

    Sex 1.6 (5.7, 8.8) 3.7 (6.3, 13.6) 4.2 (6.7, 15.0) 0.7 (5.4, 4.1)Maternal age 0.3 (0.9, 0.2) 0.5 (1.3, 0.3) 0.9 (1.6, 0.1)* 0.0 (0.4, 0.4)

    Gestational age 2.0 (0.1, 4.1) 2.2 (-1.0, 5.4) 1.8 (1.9, 5.4) 0.2 (1.3, 1.6)Birth weight 1.2 (6.3, 4.0) 4.5 (10.8, 1.9) 2.0 (9.4, 5.5) 0.5 (2.3, 3.3)Delivery type 4.1 (9.9, 1.7) 3.7 (11.9, 4.4) 6.0 (14.4, 2.5) 0.3 (4.1, 4.6)Gravidity 0.4 (5.4, 4.5) 0.2 (10.4, 10.1) 3.5 (14.4, 7.4) 0.2 (2.6, 3.0)Mother disease during pregnancy 4.1 (10.5, 2.4) 5.0 (16.6, 6.6) 14.1 (23.7, 4.5)** 8.1 (16.5, 0.3)Meconium-stained liquor 1.7 (8.0, 11.3) 0.8 (17.1, 15.4) 1.0 (16.8, 18.8) 1.6 (7.3, 4.1)Apgar score in fifth minute 1.9 (0.2, 3.7)* 2.0 (0.5, 4.4) 2.8 (0.4, 5.2)* 0.4 (2.7, 1.8)pH 16.5 (9.9, 43.0) 29.8 (12.3, 71.9) 15.9 (33.3, 65.2) 11.3 (37.4, 14.8)Base deficit 0.7 (0.1, 1.3)* 1.0 (0.2, 1.9)* 0.7 (0.4, 1.8) 0.6 (0.0, 1.2)*Bicarbonate level 0.7 (0.2, 1.3)* 1.2 (0.3, 2.1)* 0.8 (0.4, 2.0) 0.6 (0.0, 1.2)*Positive pressure ventilation 2.4 (9.1, 4.2) 0.7 (10.9, 9.5) 2.2 (8.9, 13.3) 1.2 (4.5, 6.9)Chest compression 4.8 (12.5, 3.0) 2.7 (14.5, 9.2) 3.6 (16.5, 9.3) 0.3 (9.0, 9.7)Intubation 3.2 (4.8, 11.2) 6.7 (9.0, 22.4) 5.3 (12.1, 22.8) 0.3 (9.0, 9.7)Seizure 2.0 (10.1, 6.1) 3.1 (13.2, 6.9) 5.6 (16.2, 5.0) 0.0 (5.8, 5.7)

    *P < .05, **P < .01, ***P < .001.

    4 Journal of Child Neurology 00(0)

  • 7/29/2019 Two-Year Follow-Up Study on Neurodevelopmental Outcomes After Term Intrapartum Asphyxia Using Questionaire

    6/8

    T

    able3.RegressionofAgeandStageQuestionnaireScoreinEachof5Neurode

    velopmentalAreasonMaternalandNe

    onatalFactorsat6-,12-,18-,and24-Mo

    nth-OldInfants

    N

    eurodevelopmental

    ar

    eas

    6thm

    onth

    12thmo

    nth

    18thmo

    nth

    24thm

    onth

    Variable

    Coeff.

    (95%CI)

    Variable

    Coeff.

    (95%CI)

    Variable

    Coeff.

    (95%CI)

    Variable

    Coeff.

    (95%CI)

    C

    ommunication

    Positivepressure

    ventilation

    3

    9.2

    (2.1,

    16.4

    )*

    Motherdisease

    22.9(38.7,7.2

    )**

    Motherdisease

    49.4

    (54.6,44.3

    )***

    Positivepressure

    ventilation

    3

    16.0

    (2.5,

    29.5

    )*

    G

    rossmotor

    Apgarscore

    5.3

    (1.4,

    9.3

    )*

    Apgarscore

    7.3

    (0.9,

    13.7

    )*

    Motherage

    1.7

    (3.1,0.3

    )*

    Bicarbonatelevel

    1.0

    (0.2,

    1.9

    )*

    BaseDeficit

    2.8

    (0.2,5.4

    )*

    Motherdisease

    21.3

    (42.5,0.0

    02)*

    Bicarbonatelevel

    3.1

    (0.3,

    5.9

    )*

    Apgarscore

    6.6(2.6,

    10.5

    )**

    Fi

    nemotor

    Delivery

    7.7

    (14.1,1.4

    )*

    BaseDeficit

    1.4

    (0.5,2.3

    )**

    Gravidity

    6.4

    (11.5,1.3

    )*

    Bicarbonatelevel

    1.2

    (0.0,

    2.4

    )*

    Motherdisease

    7.7

    (14.9,0.5

    )*

    Problem

    solving

    BaseDeficit

    0.9

    (0.1,1.7

    )*

    Birthweight

    5.3

    (8.8,1.8

    )**

    BaseDeficit

    1.6

    (0.2,2.9

    )*

    Bicarbonatelevel

    1.0

    (0.3,

    1.8

    )**

    Motherdisease

    17.1

    (32.1,2.1

    )*

    BaseDeficit

    1.4

    (0.5,

    2.2

    )**

    Apgarscore

    4.6

    (1.5,

    7.6

    )**

    Bicarbonatelevel

    1.1

    (0.2,

    2.1

    )*

    Seizure

    14.4

    (27.3,1.5

    )*

    Personal-social

    Apgarscore

    3.2

    (1.0,

    5.4

    )**

    Birthweight

    5.2

    (9.0,1.4

    )*

    Birthweight

    4.0

    (7.9,0.1

    )*

    BaseDeficit

    1.1

    (0.3,1.8

    )*

    Bicarbonatelevel

    1.2

    (0.5,

    1.9

    )**

    *P